MindMaze, a spin off from the Swiss Federal Institute of Technology (EPFL), is a global leader in digital neuro-therapeutics (DTx) solutions with a mission to accelerate the brain’s ability to recover, learn and adapt.
MindMaze is pioneering a breakthrough computing platform that captures brain activity upon intent, creating a new operating system for computers - a brain O/S.
MindMaze was founded in 2012 by Tej Tadi. The company is headquartered in Lausanne, Vaud, Switzerland, with offices in Baltimore, London, Paris and Mumbai.
MindMaze works at the intersection of neuroscience, bio-sensing, engineering, mixed reality and artificial intelligence, to address some of the most challenging problems in neurology, including stroke, Alzheimer disease and Parkinson disease, by creating a universal platform for brain health and recovery and unique digital therapeutic interventions.
MindMaze’s pioneering FDA cleared and CE marked neuro-digital therapeutics accelerate patients’ recovery from many critical neurological conditions. It delivers seamless digital assessments and therapeutics over the full continuum of care for thousands of patients suffering from neurological conditions.
MindMaze is advancing commercialization in the US by expanding its team and footprint in neurorehabilitation centers, and recently received Current Procedural Terminology (CPT®)1 Category III codes for asynchronous care.
MindMaze is backed by AlbaCore Capital, Concord Health Partners, Hambro Perks, Leonardo DiCaprio, Hinduja Group, Venture Kick, and others. The company raised $105M in a new round on Feb 17, 2022. This brings MindMaze's total funding to $340.7M to date. MindMaze was valued at over $1.5B from a funding raised in Oct 2021.